A detailed history of Camber Capital Management LP transactions in Pfizer Inc stock. As of the latest transaction made, Camber Capital Management LP holds 2,500,000 shares of PFE stock, worth $58.7 Million. This represents 2.38% of its overall portfolio holdings.

Number of Shares
2,500,000
Previous 5,000,000 50.0%
Holding current value
$58.7 Million
Previous $133 Million 52.24%
% of portfolio
2.38%
Previous 3.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

SELL
$25.01 - $27.13 $62.5 Million - $67.8 Million
-2,500,000 Reduced 50.0%
2,500,000 $63.4 Million
Q4 2024

Feb 14, 2025

BUY
$24.8 - $30.19 $124 Million - $151 Million
5,000,000 New
5,000,000 $133 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $132B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Camber Capital Management LP Portfolio

Follow Camber Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Camber Capital Management LP with notifications on news.